Search clinical trials for: Cryopreserved formulation

Total 2829 results

University Hospital Freiburg
Novartis

Completed

Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD) (MPH-Kinetics)

Attention Deficit Hyperactivity Disorder

Germany
Photocure

Terminated

Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers

Healthy

Norway
Rigshospitalet, Denmark
Odense University Hospital; Aalborg University Hospital

Completed

Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas

Malignant Gliomas

Denmark
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months

Influenza

Singapore
McMaster University

Unknown

Comparison of Two Formulations of Bio-K

Antibiotic-Associated Diarrhea

Canada
ISDIN

Completed

Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test

Psoriasis

Germany
Solvay Pharmaceuticals

Terminated

Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine

Healthy Subjects

Finland, Germany
GlaxoSmithKline

Completed

To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug

Healthy Subjects

United States
Cerecin

Completed

Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly

Alzheimer's Disease

United States
GlaxoSmithKline

Completed

A Two-Part Study to Determine: Best Medication Formulation and Food Effect

Overactive Bladder

United States
Zalicus

Completed

A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers

Atopic Dermatitis

Germany
Abbott

Completed

Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer

Prostatic Neoplasms

United States
Western Galilee Hospital-Nahariya

Completed

Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ?

Hemodialysis | End Stage Renal Disease

Israel
POZEN

Completed

Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations

Arthritis

United States
Phytotox SA

Withdrawn

Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles

Facial Wrinkles

Argentina
Veeda Oncology
Bristol-Myers Squibb

Completed

Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Novartis

Terminated

Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.

Proliferative Diabetic Retinopathy

Switzerland
GlaxoSmithKline

Completed

Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03

Influenza

Germany
European Malaria Vaccine Initiative
Radboud University Medical Center; GlaxoSmithKline; Biomedical Primate Research... and other collaborators

Completed

Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers

Plasmodium Falciparum Malaria

Netherlands
Teva GTC

Completed

Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease

Crohn's Disease

Israel
GlaxoSmithKline

Completed

Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y

Hepatitis B

Austria
GlaxoSmithKline

Completed

Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B

Hepatitis B

Austria
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine

Hepatitis B

Austria
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents

Hepatitis B

Germany
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants

Hepatitis B

Belgium
POZEN

Completed

Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations

Arthritis

United States
Aga Khan University
National Institute of Child Health, Karachi, Pakistan; Civil Hospital, Hyderabad...

Completed

Comparing the Efficacy of Different Zinc Formulations in the Treatment of Diarrhea (Zinc)

Incidence of Acute Diarrhea | Incidence of Abdominal Pain

Pakistan
Allergan

Completed

Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Mylan Pharmaceuticals Inc

Completed

Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day

Healthy

United States
Aeris Therapeutics

Terminated

Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

Pulmonary Emphysema

Israel
NeurogesX

Completed

Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function

Pain
Aeris Therapeutics

Completed

US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation

Pulmonary Emphysema

United States
Biolipox AB

Completed

Taste and Local Tolerance Study of NLA Nasal Spray in Patients With Allergic Rhinitis

Allergic Rhinitis

Sweden
National Eye Institute (NEI)

Completed

New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis

Cystinosis

United States
Eunice Kennedy Shriver National Institute of Child...

Completed

Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914

Healthy

United States
Hellenic Cooperative Oncology Group
University of Ioannina

Completed

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

Breast Cancer | Prostate Cancer | Non Small Cell Lung Cancer

Greece
B. Braun Melsungen AG
Tigermed Consulting Co., Ltd; B. Braun Medical International Trading Company...

Completed

Efficacy and Safety Study of Two Propofol Formulations

General Anaesthesia | Induction of Anaesthesia

China
Solvay Pharmaceuticals

Completed

Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis)

Knee Osteoarthritis

France
BioPartners GmbH
LG Life Sciences

Completed

Sustained Release Formulation of Somatropin (rDNA Origin)for Injection

Growth Hormone Deficiency
Dafra Pharma
Kenya Medical Research Institute

Completed

Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria

Malaria, Falciparum

Kenya
NeurogesX

Completed

Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain

HIV Infections | Pain | Diabetes Mellitus | Diabetic Neuropathies | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster | Polyneuropathies

United States
Braintree Laboratories

Completed

A Safety and Efficacy Evaluation of 3 Bowel Preparations in the Pediatric Population

Colonoscopy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 3 New Formulations of SKI-606 in Healthy Adult Subjects

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens

Healthy
MediQuest Therapeutics

Completed

Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon

Raynaud's Disease

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation

Estrogen Replacement Therapy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro)

Postmenopause

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B

Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Bioavailability of Oral Formulations of Vabicaserin

Schizophrenia

United States

3

Subscribe